1/20
Looks like no tags are added yet.
1906: The Pure Food and Drug Act (PFDA)
This act required all foods and drugs to meet a standard of strength and purity.
1914: The Harrison Narcotic Act
This act regulated drugs that produced or sustain physical of psychological dependence. The importation, sale, manufacture, and use of: Opium, Marijuana, Synthetic Agents, Derivatives.
1938: The Federal Food, Drug, and Cosmetic Act (FFDCA)
Manufactures of drugs and cosmetics must prove that their products are safe. Medical devices must be proved effective. This gave the FDA limited authority to remove products from the marketplace if they are found to be ineffective or unsafe.
Misbranded Drugs
Any drug that contains false and/or misleading information and/or omits proper warnings and instructions.
Adulterated Drugs
Any drug that contains decomposed substances.
1951: The Durham-Humphrey Amendments to the FFDCA
Further clarified the distinction between prescription and over-the-counter (OTC) drugs based on whether or not the drugs were habit-forming, narcotic, hypnotic, or potentially harmful.
Legend Drugs
(Prescription Drugs): Drugs that can only be given with a prescription.
OTC Drugs
(Over-the-counter) Drugs that can be given without a prescription.
1962: The Kewfauver-Harris Amendments to the FFDCA
This required drug manufactures to prove the safety and efficacy of their products before approval was given by the FDA for marketing.
1970: Poison Prevention Packaging Act
This act requires child-proof packaging.
1970: Controlled Substances Act (CSA)
Classified drugs based on their potential for abuse, Schedule I, II, III, IV, and V. Federal law requires that all controlled substances dispensed bear the following: "Federal law prohibits the transfer of this drug to any person other than patient for whom prescribed."
JCAHO (Joint Commission on Accreditation of Health Care Organizations)
The mission of the JCAHO is to improve the quality of care provided to the general public. JCAHO is responsible for accreditation of institutional settings.
U.S Department of Labor Occupational Safety and Health Organizations
OSHA is responsible for the safety in the work place.
The American Association of Pharmacy Technicians (AAPT) Founded in 1979
The American Association of Pharmacy Technicians (AAPT) set forth a code of ethics that details the responsibilities of the pharmacy technician while protecting their right to due process. The code has ten points that promotes practical and common sense standards of professionalism and integrity.
1987: Prescription Drug Marketing Act of 1987 (PDMA)
PDMA is a part of the FDC Act, which was enacted to address certain prescription drug-marketing practices that have contributed to the diversion of drugs into a secondary gray market.
1990: Omnibus Budget Reconciliation Act (OBRA-90)
This act required pharmacists to offer counseling to Medicaid patients regarding medications.
The Anabolic Steroids Control Act of 1990
This Act places "any drug or hormonal substance chemically and pharmacologically related to testosterone" under regulatory provisions of the Controlled Substances Act.
1996: Health Insurance Portability and Accountability Act of 1996 (HIPAA)
HIPAA is the most significant piece of federal legislation to affect pharmacy practice since OBRA-90. The privacy rule component of HIPAA took effect on April 14, 2003, and was the first comprehensive federal regulation designed to safeguard the privacy of protected health information (PHI)
1997: FDA Modernization Act
This act changed the legend requirements to "Rx Only" to be phased in by February 2003.
2003: Medicare Prescription Drug, Improvement, and Modernization Act (also called the Medicare Modernization Act or MMA)
This act produced the largest overhaul of Medicare in the public health program's history. The MMA was signed on December 8, 2003 creating Medicare Part D. These programs subsidize the costs the prescription drugs for Medicare beneficiaries and went into effect on January 1, 2006.
2005: The Patient Safety and Quality Improvement Act of 2005
signed into law on July 29, 2005, was enacted in response to growing concern about patient safety in the United States and the Institute of Medicine's (IOM) 1999 report. The goal of this act is to improve patient safety by encouraging voluntary and confidential reporting of events that adversely affect patients.